Rather than a “new study” post, this is about a new retraction of a 2022 study of treating aging-associated decline. The experiment supports a drug, and the lead researcher advises the company that’s making it. And one of the co-authors calls it a conspiracy. 🙄 Against pharmaceutical research? An odd gambit! The concerns about the paper seem like a more serious version of the usual sort of quibbles about most papers, but the journal decided it was just a bit too much to tolerate. May...
